Vivian Huong Hoang Thien Le

Vivian Huong Hoang Thien Le

Auto-generated profile, based on publicly available information

Vivian Huong Hoang Thien Le

Faculty of Medicine , University of Montreal , Montreal , Canada , umontreal.ca

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 September 2025 in The Journal of Spinal Cord Medicine
Verified
Journal Article
Closed access
VLVivian Huong Hoang Thien Le
Vivian Huong Hoang Thien Le
PMPascal Mputu Mputu
Pascal Mputu Mputu
ARAndréane Richard-Denis
Andréane Richard-Denis
FBFrancis Bernard
Francis Bernard
YCYiorgos Alexandros Cavayas
Yiorgos Alexandros Cavayas
JMJean-Marc Mac-Thiong
Jean-Marc Mac-Thiong
A retrospective study with a crossover design. Maintaining mean arterial pressure (MAP) is crucial in the early management of SCI, yet the role of oral midodrine in this setting remains unclear. This study evaluates whether midodrine facilitates IV vasopressor weaning within 24 hours of initiation. The study was conducted at a Level 1 trauma center. A cohort of 28 patients was analyzed. MAP levels and IV vasopressor dosages were recorded 24 hours before and after midodrine initiation. The primary outcome was reduced IV vasopressor use while maintaining MAP targets. Midodrine was started on average 4.0±1.9 days after initiation of intravenous vasopressor therapy. Twenty-two individuals (78.6%) received less intravenous vasopressors during the 24-hour period after initiation of midodrine. Mean MAP remained similar 24 hours before vs. after initiation of midodrine (90.4±3.3 vs. 88.6±5.1 mm Hg). Earlier introduction of midodrine was significantly related to more rapid weaning and reduced total duration of intravenous vasopressor therapy. Initiating oral midodrine in the ICU within 7 days of a traumatic SCI resulted in a rapid decrease in intravenous vasopressor requirements in close to 80% of people while maintaining MAP targets, therefore supporting the potential of midodrine to accelerate the weaning of intravenous vasopressors.

1 January 2026 in International Journal of Breast Cancer
Verified
Journal Article
Open access
PDF file
LOLeonardo Olijnyk
Leonardo Olijnyk
VLVivian Huong Hoang Thien Le
Vivian Huong Hoang Thien Le
EFEdisond Florial
Edisond Florial
FAFidaa Al-Shakfa
Fidaa Al-Shakfa
JMJean-Marc Mac-Thiong
Jean-Marc Mac-Thiong
ZWZhi Wang
Zhi Wang
Background: Breast cancer is the most commonly diagnosed malignancy among women globally, with spinal metastases significantly impacting morbidity and mortality. Surgical intervention plays a crucial role in managing symptomatic spinal lesions, yet prognostic factors and outcomes remain areas of active investigation. This study aims to evaluate survival rates and identify predictors in patients with breast cancer undergoing surgery for spinal metastases. Methods: A retrospective analysis was conducted on 97 patients who underwent surgery for spinal breast cancer metastases at a single center over a 12‐year period. Data included epidemiological and preoperative profiles, biological markers, and radiological findings. Survival outcomes were assessed using Kaplan–Meier analysis, and prognostic factors were analyzed via Cox regression. Results: Postoperative overall survival rates were 72%, 64%, and 34% at 1, 2, and 5 years, respectively. Significant predictors of survival included tobacco use (HR 1.7, p = 0.025), estrogen receptor (HR 0.224, p = 0.03), triple‐negative subtype (HR 4.1, p < 0.01), and lower Karnofsky scores (HR 0.488, p < 0.01). Spinal instability and preoperative neurological status did not significantly influence survival. Complications occurred in 17% of patients, with no 30‐day mortality. Conclusion: This study provides one of the largest single‐center experiences of surgery for spinal metastases from breast cancer in the modern treatment era. We found that overall preoperative performance and biological markers, remains a key predictor of survival, while neurological status, disease spread and spinal instability have no impact than in long‐term survival. These results reflect advances in systemic therapy and surgical care, supporting surgery as an important part of multidisciplinary management for selected patients.